France
41553 clinical trials
Find TrialsClinical Trials (41553)
A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular Disorders
Does the Stapled Transanal Rectal Resection (STARR Procedure) Has an Effect on Anal Compliance ?
Does the National Health Insurance Card Allow us to Predict Antibiotic Resistance?
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
Phase I Single-blind Clinical Trial to Evaluate the Safety and Local Immune Activation of a Toll-like Receptor 5 Agonist (FLAMOD) Administered by Aerosol
Oligogenic Determinism of Colorectal Cancer
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Diagnostic and Prognostic Markers of Endometriosis in Menstrual Blood
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
Impact of Thymectomy on Immunity in Infants After Cardiac Surgery
Non Invasive Ventilation and Weaning : VENISE Trial
Cerebello-motor Neuromodulation After Stroke. CERSTIM.
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
Evaluation of the Impact of Physical Reconditioning Associated With Specific Nutritional Supplementation in Obese Patients Suffering From Metabolic Syndrome
Burosumab and 1-25 (OH) Vitamin D on Human Osteoblasts